Respiri
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - non WARespiri Limited (RSH, formerly iSonea Limited) is a medical technology company developing devices and mobile health applications to improve the management of chronic, costly respiratory disorders.
Respiri's clinically proven patented technology is used in major hospitals in UK, Europe, USA, Japan, Korea and Australia.
Contact Details
Suite 1, Level 9, 432 St Kilda Road, MELBOURNE VIC 3004
03 9602 3366
Lists and Charts
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Respiri | $1.4m |
1334 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Total Shareholder Return as at 29/04/22
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1654th | Respiri | -50% | -13% |
1811 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Company Activity
| NEW ROLE: Samaneh Sarraf Shiraz, Chief Research Officer | 24 Nov 2020 |
| NEW ROLE: Samaneh Sarraf Shirazi, | 24 Nov 2020 |
| NEW ROLE: Philippe Ludekens, | 24 Nov 2020 |
| NEW ROLE: Koswani Wall, | 24 Nov 2020 |
| REMUNERATION UPDATE: Nicholas Smedley, Executive Chair | 13 Nov 2020 |
| REMUNERATION UPDATE: Marjan Mikel, Executive Director, Chief Executive Officer, Managing Director | 13 Nov 2020 |
| REMUNERATION UPDATE: Tom Duthy, Non-Executive Director | 13 Nov 2020 |
| NEW ROLE: Marjan Mikel, Executive Director, Chief Executive Officer, Managing Director | 03 Nov 2020 |
| NEW ROLE: Tom Duthy, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Nicholas Smedley, Executive Chair | 03 Nov 2020 |
